🟢 Generate Biomedicines is trading 5% up in pre-market as Nasdaq Composite rises 0.94%

Generate Biomedicines is trading 4.89% up at $16.93, with the broader market supportive as the Nasdaq Composite rises 0.94%.

• Shares declined 20.80% on August 26, 2026.
• Futures are higher, but no fresh company-specific announcement clearly explains the pre-market rebound.
• Investors may be reassessing the post-IPO lock-up expiration effective August 26, which contributed to recent volatility.